Ghana Medical Trust Fund, MDS-Lancet and Quest Medical Imaging team up to boost diagnostic healthcare access

Ghana's healthcare landscape is set for a significant upgrade as the Ghana Medical Trust Fund (GMTF), MDS-Lancet Laboratories Ghana Limited and Quest Medical Imaging have formally sealed a partnership to enhance diagnostic services nationwide. The collaboration aims to address gaps in disease detection and improve clinical decision-making, particularly for patients managing chronic and non-communicable diseases that increasingly burden the country's health system.

The strategic agreement brings together complementary strengths: GMTF's mandate to support prevention and treatment of non-communicable diseases, combined with the laboratory expertise of MDS-Lancet and the imaging capabilities of Quest Medical Imaging. Officials say the partnership is designed to ensure Ghanaians have timely access to accurate diagnostic testing, a critical foundation for effective treatment planning.

Strengthening Ghana's diagnostic capacity

During the signing ceremony, Ghana Medical Trust Fund Administrator Adjoa Obuobia Darko-Opoku emphasised that accurate and timely diagnostics form the cornerstone of effective treatment. She highlighted that the partnership represents a concrete investment in improving healthcare accessibility across the country, reflecting all three institutions' commitment to quality care.

Dr Paul Sekyere-Nyantakyi, Chief Executive Officer of MDS-Lancet Laboratories Ghana Limited, welcomed the initiative as aligned with the company's mission to deliver high-quality diagnostic services that support improved patient outcomes. The partnership is expected to broaden access to advanced testing capabilities, particularly benefiting communities that have traditionally faced barriers to reliable diagnostic facilities.

Why this matters for Ghana

Ghana faces a growing burden of non-communicable diseases—including diabetes, hypertension, cancer and cardiovascular conditions—which account for a substantial proportion of the nation's disease burden. Early, accurate diagnosis is essential for managing these conditions effectively and reducing complications, yet many Ghanaians still lack consistent access to reliable diagnostic services.

This partnership addresses that gap by leveraging both laboratory testing and medical imaging under one collaborative framework. By improving diagnostic accessibility and reliability, the institutions aim to enable earlier disease detection, which can significantly improve treatment outcomes and reduce healthcare costs long-term. For patients in regions with limited diagnostic infrastructure, the collaboration could be transformative.

The three partners have committed to building a long-term relationship founded on trust, excellence and shared health outcomes. Officials expressed confidence that the initiative will deliver measurable value to patients and contribute to equitable, sustainable healthcare advancement across Ghana. The partnership also reflects a broader trend in Ghana's health sector toward strategic collaborations that leverage private expertise and institutional mandates to strengthen public health outcomes.